ArticleFrontiers in immunology2026

Case Report: Complete metabolic responses to trastuzumab-deruxtecan in HER2-altered solid tumors: two illustrative cases.

Coline Le Meur et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.